Isis presents clinical data at AACR-NCI-EORTC meeting; Novartis withdraws from collaboration Nov. 29, 1999
Geldanamycin derivative with selective activity against breast cancer developed at Sloan-Kettering Nov. 26, 1999
Novel antitumor agents for both leukemias and solid tumors discovered by Taiwanese scientists Nov. 26, 1999
AACR-NCI-EORTC news: Japanese research team presents new hypoxic cell radiosensitizing agent Nov. 25, 1999
RSS